期刊文献+

肠球菌属细菌的临床分布及耐药性分析 被引量:3

Analysis on clinical distribution and drug resistance of Enterococcus spp
下载PDF
导出
摘要 目的 分析我院肠球菌属在临床标本中的分布 (临床分布 )及耐药状况。方法 应用Sensititre全自动细菌鉴定系统鉴定菌种 ;用纸片扩散法和Etest法进行药敏试验。结果 肠球菌分离率分别为尿液 38%、脓汁 19%、痰液 14 %、引流液 10 %、其他标本 19%。 91株肠球菌中粪肠球菌 6 7%、屎肠球菌 32 %、坚忍肠球菌 1%。粪肠球菌和屎肠球菌庆大霉素高耐株达 5 0 %以上。屎肠球菌对 β 内酰胺类抗生素的耐药率明显高于粪肠球菌 ,未发现万古霉素耐药株 ,但有两株Etest法呈中介水平。结论 肠球菌在我院临床标本中分布较广 ,以粪肠球菌和屎肠球菌为主 ;除对万古霉素敏感外 。 Objective To study distribution and drug resistance of Enterococcus spp in our hospital.Methods Enterococci were identified by Sensititre Microbiology System. The antimicrobial susceptibility was tested by using agar dilution method and Etest. Results Enterococci were isolated from urine(38%),pus(19%),sputum(14%),abdominal drainage(10%) and other specimens(19%), respectively.There were 67% E.faecalis, 32% E.Faecium and 1%E.durans among ninety one strains of enterococci.There were more than 50% E.faecalis and E.Faecium which were resistance to high level gentamicins.Resistant rate to β Lactams of E.Faecium was higher than E.faecalis .The strains of resistance to vancomycin were not found but two strains of intermediate to vancomycin were detected by Etest.Conclusion Enterococci distribute to clinical specimens widely. E.faecalis and E.Faecium are the most species.Most of them were resistant to many kind of antimicrobial agents except vancomycin.
出处 《哈尔滨医科大学学报》 CAS 2003年第1期69-71,共3页 Journal of Harbin Medical University
  • 相关文献

参考文献4

二级参考文献7

共引文献185

同被引文献53

  • 1罗燕萍,白立彦,李俊玲,许淑秀.211株肠球菌属细菌对18种抗生素的耐药性特征[J].中华医院感染学杂志,2004,14(1):80-82. 被引量:68
  • 2林红燕,沈怀亮,魏衍超.临床检出肠球菌耐药谱4年的变迁[J].中华医院感染学杂志,2005,15(1):115-117. 被引量:25
  • 3朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 4李娟,冯晖,赵进.肠球菌的临床分布特征及耐药性分析[J].实用医技杂志,2005,12(09A):2354-2355. 被引量:8
  • 5Harris Anthony D,Nemoy Lucia,Johnson.Co-carriage rates of VRE and extended-spectrumbeta-lactamase producmg bacteria among a cohort of intensive care unit patients:implications for an active surveillance program[J].Infection control&Hospital epidemiology,2004,25(2):105-108.
  • 6Sievebt DM,Boulton ML,Stoltman G,et al.Staphylococcus aureus to vancomycin-United States[J].MMWR,2002,51:567.
  • 7Centers for Disease Control and Prevention.VRSA:Pennsylvania,2002,MMWR,2002,51:902.
  • 8Infection with VRSA containing the VanA Resistance Gene[J].Infectious Disease in Clinical Practice,2002,11(8):490.
  • 9Goldstein FW,Percentages and distrigbutions of teicoplanin and vancomycin resistant strains among coagulase-negative staphylococci[J].Antimicrob Agents Chemother,1990,34:889.
  • 10Leggiadro,Robert J M D.The emergence of decrease susceptibility to vancomycin in staphylococcus epidermidis[J].Pediatric Infectious Disease Journal,1999,18(9):848.

引证文献3

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部